VOLPE, Alessandro
VOLPE, Alessandro
Dipartimento di Medicina Traslazionale
2021 Updated European Association of Urology Guidelines on the Use of Adjuvant Pembrolizumab for Renal Cell Carcinoma
2022-01-01 Bedke, J.; Albiges, L.; Capitanio, U.; Giles, R. H.; Hora, M.; Lam, T. B.; Ljungberg, B.; Marconi, L.; Klatte, T.; Volpe, A.; Abu-Ghanem, Y.; Dabestani, S.; Fernandez-Pello, S.; Hofmann, F.; Kuusk, T.; Tahbaz, R.; Powles, T.; Bex, A.
[18F]FDG-PET/CT in adrenal lesions: diagnostic performance in different clinical settings
2024-01-01 Romanisio, Martina; Daffara, Tommaso; Pitino, Rosa; Ferrero, Alice; Pizzolitto, Francesca; Zavattaro, Marco; Biello, Federica; Gennari, Alessandra; Volpe, Alessandro; Sacchetti, Gian Mauro; Marzullo, Paolo; Aimaretti, Gianluca; Prodam, Flavia; Caputo, Marina
A Global Trend Analysis of Kidney Cancer Incidence and Mortality and Their Associations with Smoking, Alcohol Consumption, and Metabolic Syndrome
2021-01-01 Huang, J.; Leung, D. K. -W.; Chan, E. O. -T.; Lok, V.; Leung, S.; Wong, I.; Lao, X. -Q.; Zheng, Z. -J.; Chiu, P. K. -F.; Ng, C. -F.; Wong, J. H. -M.; Volpe, A.; Merseburger, A. S.; Powles, T.; Teoh, J. Y. -C.; Wong, M. C. S.
A Joint Statement from the European Association of Urology Renal Cell Cancer Guidelines Panel and the International Kidney Cancer Coalition: The Rejection of Ipilimumab and Nivolumab for Renal Cancer by the Committee for Medicinal Products for Human Use Does not Change Evidence-based Guideline Recommendations
2018-01-01 Bex, A.; Albiges, L.; Staehler, M.; Bensalah, K.; Giles, R. H.; Dabestani, S.; Hofmann, F.; Hora, M.; Kuczyk, M. A.; Lam, T. B.; Marconi, L.; Merseburger, A. S.; Fernandez-Pello, S.; Tahbaz, R.; Abu-Ghanem, Y.; Volpe, A.; Ljungberg, B.; Escudier, B.; Powles, T.
A Systematic Review and Meta-analysis Comparing the Effectiveness and Adverse Effects of Different Systemic Treatments for Non-clear Cell Renal Cell Carcinoma
2017-01-01 Fernández Pello, Sergio; Hofmann, Fabian; Tahbaz, Rana; Marconi, Lorenzo; Lam, Thomas B; Albiges, Laurence; Bensalah, Karim; Canfield, Steven E; Dabestani, Saeed; Giles, Rachel H; Hora, Milan; Kuczyk, Markus A; Merseburger, Axel S; Powles, Thomas; Staehler, Michael; Volpe, Alessandro; Ljungberg, Börje; Bex, Axel
Active surveillance for clinically localized renal tumors: An updated review of current indications and clinical outcomes
2015-01-01 Borghesi, Marco; Brunocilla, Eugenio; Volpe, Alessandro; Dababneh, Hussam; Pultrone, Cristian Vincenzo; Vagnoni, Valerio; La Manna, Gaetano; Porreca, Angelo; Martorana, Giuseppe; Schiavina, Riccardo
An over-view of robot assisted surgery curricula and the status of their validation
2015-01-01 Fisher, Ra; Dasgupta, P; Mottrie, A; Volpe, Alessandro; Khan, Ms; Challacombe, B; Ahmed, K.
Anatomic classification systems of renal tumors: new, useful tools in renal surgical oncology
2011-01-01 Volpe, Alessandro; Terrone, Carlo
Apoptotic and predictive factors by Bax, Caspases 3/9, Bcl-2, p53 and Ki-67 in prostate cancer after 12 Gy single-dose.
2020-01-01 Pisani, Carla; Ramella, Martina; Boldorini, Renzo Luciano; Loi, Gianfranco; Billia, Michele; Boccafoschi, Francesca; Volpe, Alessandro; Krengli, Marco
Assessment of predictors of renal cell carcinoma progression after nephrectomy at short and intermediate term follow-up and implication on surveillance protocols
2021-01-01 Perri, Davide; Palumbo, Carlotta; Billia, Michele; Umari, Paolo; Zacchero, Monica; D'Agate, Daniele; Bondonno, Gianmarco; Volpe, Alessandro
Assessment of risk factors for complications of laparoscopic partial nephrectomy
2007-01-01 F., Porpiglia; Volpe, Alessandro; M., Billia; J., Renard; R. M., Scarpa
Assessment of volume preservation performed before or after partial nephrectomy accurately predicts postoperative renal function: Results from a prospective multicenter study
2019-01-01 Klingler, M. J.; Babitz, S. K.; Kutikov, A.; Campi, R.; Hatzichristodoulou, G.; Sanguedolce, F.; Brookman-May, S.; Akdogan, B.; Capitanio, U.; Roscigno, M.; Volpe, A.; Marszalek, M.; Uzzo, R. G.; Antonelli, A.; Langenhuijsen, J.; Carini, M.; Minervini, A.; Lane, B. R.
Author reply to letter to the editor re: The natural history of incidentally detected small renal masses
2004-01-01 Volpe, Alessandro; M. A. S., Jewett; A. J., Evans
Biopsy and treatment decisions in the initial management of prostate cancer and the role of PCA3: a systematic analysis of expert opinion
2012-01-01 Tombal, B; Ameye, F; DE LA TAILLE, A; DE REIJKE, T; Gontero, P; Haese, A; Kil, P; Perrin, P; Remzi, M; Schröder, J; Speakman, M; Volpe, Alessandro; Meesen, B; Stoevelaar, H.
Bladder cancer following renal transplantation: experiences with radical cystectomy and adjuvant radiotherapy
2020-01-01 Panarello, Daniele; Quaglia, Marco; Mantica, Guglielmo; Cantaluppi, Vincenzo; Krengli, Marco; Volpe, Alessandro; Terrone, Carlo
Can emerging level 1 evidence "discourage" elective nephron-sparing surgery for small renal tumors?
2011-01-01 Terrone, Carlo; Volpe, Alessandro
Carcinoma prostatico: trattamento con ultrasuoni focalizzati ad alta frequenza della recidiva locale su anastomosi dopo prostatectomia
2006-01-01 M., Tasso; Volpe, Alessandro; F., Varvello; U., Ferrando
Caso clinico di PDD con esaminolevulinato
2009-01-01 Volpe, Alessandro; Zanellato, I; Billia, M; Varvello, F; Sogni, F; Terrone, Carlo
Changes in prostate cancer at radical prostatectomy during the prostate specific antigen era: an Italian experience
2008-01-01 Bollito, E; Terrone, Carlo; Volpe, Alessandro; Porpiglia, F; Cracco, C; Poggio, M; Grande, S; Righi, L; Bellina, M; Papotti, M; Scarpa, Rm
Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series
2012-01-01 Volpe, Alessandro; Novara, G; Antonelli, A; Bertini, R; Billia, M; Carmignani, G; Cunico, Sc; Longo, N; Martignoni, G; Minervini, A; Mirone, V; Simonato, A; Terrone, Carlo; Zattoni, F; Ficarra, V; members of the, Surveillance; Treatment Update on Renal Neoplasms Project Leading Urological No Profit Foundation for Advanced Research, Foundation
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| 2021 Updated European Association of Urology Guidelines on the Use of Adjuvant Pembrolizumab for Renal Cell Carcinoma | 1-gen-2022 | Bedke, J.; Albiges, L.; Capitanio, U.; Giles, R. H.; Hora, M.; Lam, T. B.; Ljungberg, B.; Marconi, L.; Klatte, T.; Volpe, A.; Abu-Ghanem, Y.; Dabestani, S.; Fernandez-Pello, S.; Hofmann, F.; Kuusk, T.; Tahbaz, R.; Powles, T.; Bex, A. | |
| [18F]FDG-PET/CT in adrenal lesions: diagnostic performance in different clinical settings | 1-gen-2024 | Romanisio, Martina; Daffara, Tommaso; Pitino, Rosa; Ferrero, Alice; Pizzolitto, Francesca; Zavattaro, Marco; Biello, Federica; Gennari, Alessandra; Volpe, Alessandro; Sacchetti, Gian Mauro; Marzullo, Paolo; Aimaretti, Gianluca; Prodam, Flavia; Caputo, Marina | |
| A Global Trend Analysis of Kidney Cancer Incidence and Mortality and Their Associations with Smoking, Alcohol Consumption, and Metabolic Syndrome | 1-gen-2021 | Huang, J.; Leung, D. K. -W.; Chan, E. O. -T.; Lok, V.; Leung, S.; Wong, I.; Lao, X. -Q.; Zheng, Z. -J.; Chiu, P. K. -F.; Ng, C. -F.; Wong, J. H. -M.; Volpe, A.; Merseburger, A. S.; Powles, T.; Teoh, J. Y. -C.; Wong, M. C. S. | |
| A Joint Statement from the European Association of Urology Renal Cell Cancer Guidelines Panel and the International Kidney Cancer Coalition: The Rejection of Ipilimumab and Nivolumab for Renal Cancer by the Committee for Medicinal Products for Human Use Does not Change Evidence-based Guideline Recommendations | 1-gen-2018 | Bex, A.; Albiges, L.; Staehler, M.; Bensalah, K.; Giles, R. H.; Dabestani, S.; Hofmann, F.; Hora, M.; Kuczyk, M. A.; Lam, T. B.; Marconi, L.; Merseburger, A. S.; Fernandez-Pello, S.; Tahbaz, R.; Abu-Ghanem, Y.; Volpe, A.; Ljungberg, B.; Escudier, B.; Powles, T. | |
| A Systematic Review and Meta-analysis Comparing the Effectiveness and Adverse Effects of Different Systemic Treatments for Non-clear Cell Renal Cell Carcinoma | 1-gen-2017 | Fernández Pello, Sergio; Hofmann, Fabian; Tahbaz, Rana; Marconi, Lorenzo; Lam, Thomas B; Albiges, Laurence; Bensalah, Karim; Canfield, Steven E; Dabestani, Saeed; Giles, Rachel H; Hora, Milan; Kuczyk, Markus A; Merseburger, Axel S; Powles, Thomas; Staehler, Michael; Volpe, Alessandro; Ljungberg, Börje; Bex, Axel | |
| Active surveillance for clinically localized renal tumors: An updated review of current indications and clinical outcomes | 1-gen-2015 | Borghesi, Marco; Brunocilla, Eugenio; Volpe, Alessandro; Dababneh, Hussam; Pultrone, Cristian Vincenzo; Vagnoni, Valerio; La Manna, Gaetano; Porreca, Angelo; Martorana, Giuseppe; Schiavina, Riccardo | |
| An over-view of robot assisted surgery curricula and the status of their validation | 1-gen-2015 | Fisher, Ra; Dasgupta, P; Mottrie, A; Volpe, Alessandro; Khan, Ms; Challacombe, B; Ahmed, K. | |
| Anatomic classification systems of renal tumors: new, useful tools in renal surgical oncology | 1-gen-2011 | Volpe, Alessandro; Terrone, Carlo | |
| Apoptotic and predictive factors by Bax, Caspases 3/9, Bcl-2, p53 and Ki-67 in prostate cancer after 12 Gy single-dose. | 1-gen-2020 | Pisani, Carla; Ramella, Martina; Boldorini, Renzo Luciano; Loi, Gianfranco; Billia, Michele; Boccafoschi, Francesca; Volpe, Alessandro; Krengli, Marco | |
| Assessment of predictors of renal cell carcinoma progression after nephrectomy at short and intermediate term follow-up and implication on surveillance protocols | 1-gen-2021 | Perri, Davide; Palumbo, Carlotta; Billia, Michele; Umari, Paolo; Zacchero, Monica; D'Agate, Daniele; Bondonno, Gianmarco; Volpe, Alessandro | |
| Assessment of risk factors for complications of laparoscopic partial nephrectomy | 1-gen-2007 | F., Porpiglia; Volpe, Alessandro; M., Billia; J., Renard; R. M., Scarpa | |
| Assessment of volume preservation performed before or after partial nephrectomy accurately predicts postoperative renal function: Results from a prospective multicenter study | 1-gen-2019 | Klingler, M. J.; Babitz, S. K.; Kutikov, A.; Campi, R.; Hatzichristodoulou, G.; Sanguedolce, F.; Brookman-May, S.; Akdogan, B.; Capitanio, U.; Roscigno, M.; Volpe, A.; Marszalek, M.; Uzzo, R. G.; Antonelli, A.; Langenhuijsen, J.; Carini, M.; Minervini, A.; Lane, B. R. | |
| Author reply to letter to the editor re: The natural history of incidentally detected small renal masses | 1-gen-2004 | Volpe, Alessandro; M. A. S., Jewett; A. J., Evans | |
| Biopsy and treatment decisions in the initial management of prostate cancer and the role of PCA3: a systematic analysis of expert opinion | 1-gen-2012 | Tombal, B; Ameye, F; DE LA TAILLE, A; DE REIJKE, T; Gontero, P; Haese, A; Kil, P; Perrin, P; Remzi, M; Schröder, J; Speakman, M; Volpe, Alessandro; Meesen, B; Stoevelaar, H. | |
| Bladder cancer following renal transplantation: experiences with radical cystectomy and adjuvant radiotherapy | 1-gen-2020 | Panarello, Daniele; Quaglia, Marco; Mantica, Guglielmo; Cantaluppi, Vincenzo; Krengli, Marco; Volpe, Alessandro; Terrone, Carlo | |
| Can emerging level 1 evidence "discourage" elective nephron-sparing surgery for small renal tumors? | 1-gen-2011 | Terrone, Carlo; Volpe, Alessandro | |
| Carcinoma prostatico: trattamento con ultrasuoni focalizzati ad alta frequenza della recidiva locale su anastomosi dopo prostatectomia | 1-gen-2006 | M., Tasso; Volpe, Alessandro; F., Varvello; U., Ferrando | |
| Caso clinico di PDD con esaminolevulinato | 1-gen-2009 | Volpe, Alessandro; Zanellato, I; Billia, M; Varvello, F; Sogni, F; Terrone, Carlo | |
| Changes in prostate cancer at radical prostatectomy during the prostate specific antigen era: an Italian experience | 1-gen-2008 | Bollito, E; Terrone, Carlo; Volpe, Alessandro; Porpiglia, F; Cracco, C; Poggio, M; Grande, S; Righi, L; Bellina, M; Papotti, M; Scarpa, Rm | |
| Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series | 1-gen-2012 | Volpe, Alessandro; Novara, G; Antonelli, A; Bertini, R; Billia, M; Carmignani, G; Cunico, Sc; Longo, N; Martignoni, G; Minervini, A; Mirone, V; Simonato, A; Terrone, Carlo; Zattoni, F; Ficarra, V; members of the, Surveillance; Treatment Update on Renal Neoplasms Project Leading Urological No Profit Foundation for Advanced Research, Foundation |